These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

362 related items for PubMed ID: 20967365

  • 1. A tiered procedure for assessing the formation of biotransformation products of pharmaceuticals and biocides during activated sludge treatment.
    Kern S, Baumgartner R, Helbling DE, Hollender J, Singer H, Loos MJ, Schwarzenbach RP, Fenner K.
    J Environ Monit; 2010 Nov; 12(11):2100-11. PubMed ID: 20967365
    [Abstract] [Full Text] [Related]

  • 2. High-throughput identification of microbial transformation products of organic micropollutants.
    Helbling DE, Hollender J, Kohler HP, Singer H, Fenner K.
    Environ Sci Technol; 2010 Sep 01; 44(17):6621-7. PubMed ID: 20799730
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Characterization of metoprolol biodegradation and its transformation products generated in activated sludge batch experiments and in full scale WWTPs.
    Rubirola A, Llorca M, Rodriguez-Mozaz S, Casas N, Rodriguez-Roda I, Barceló D, Buttiglieri G.
    Water Res; 2014 Oct 15; 63():21-32. PubMed ID: 24973729
    [Abstract] [Full Text] [Related]

  • 7. Assessing exposure to transformation products of soil-applied organic contaminants in surface water: comparison of model predictions and field data.
    Kern S, Singer H, Hollender J, Schwarzenbach RP, Fenner K.
    Environ Sci Technol; 2011 Apr 01; 45(7):2833-41. PubMed ID: 21370857
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada.
    Lishman L, Smyth SA, Sarafin K, Kleywegt S, Toito J, Peart T, Lee B, Servos M, Beland M, Seto P.
    Sci Total Environ; 2006 Aug 31; 367(2-3):544-58. PubMed ID: 16697441
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Occurrence, partition and removal of pharmaceuticals in sewage water and sludge during wastewater treatment.
    Jelic A, Gros M, Ginebreda A, Cespedes-Sánchez R, Ventura F, Petrovic M, Barcelo D.
    Water Res; 2011 Jan 31; 45(3):1165-76. PubMed ID: 21167546
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pharmaceutical compounds in the wastewater process stream in Northwest Ohio.
    Spongberg AL, Witter JD.
    Sci Total Environ; 2008 Jul 01; 397(1-3):148-57. PubMed ID: 18396321
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Use of an accurate-mass database for the systematic identification of transformation products of organic contaminants in wastewater effluents.
    Gómez-Ramos Mdel M, Pérez-Parada A, García-Reyes JF, Fernández-Alba AR, Agüera A.
    J Chromatogr A; 2011 Nov 04; 1218(44):8002-12. PubMed ID: 21955781
    [Abstract] [Full Text] [Related]

  • 18. Using bioprocess stoichiometry to build a plant-wide mass balance based steady-state WWTP model.
    Ekama GA.
    Water Res; 2009 May 04; 43(8):2101-20. PubMed ID: 19345392
    [Abstract] [Full Text] [Related]

  • 19. Removal of pharmaceuticals and fragrances in biological wastewater treatment.
    Joss A, Keller E, Alder AC, Göbel A, McArdell CS, Ternes T, Siegrist H.
    Water Res; 2005 Sep 04; 39(14):3139-52. PubMed ID: 16043210
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.